| Yan Gu, MD | |
|
510 Township Line Rd Ste 110, Blue Bell, PA 19422-2721 | |
| (267) 339-3558 | |
| (267) 339-3763 |
| Full Name | Yan Gu |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 34 Years |
| Location | 510 Township Line Rd Ste 110, Blue Bell, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255569596 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand View Hospital | Sellersville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reconstructive Orthopaedic Associates Ii Llc | 7416845318 | 263 |
News Archive
In patients with non-small-cell lung cancer, rare epidermal growth factor receptor mutations are associated with a poorer response to EGFR–tyrosine kinase inhibitors compared with frequently occurring ones, according to a study published in Lung Cancer.
More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today at the 56th Annual Meeting of the American Society of Hematology.
A team led by University of Iowa researchers has identified a gene linked to rare, often fatal kidney-related birth defects.
› Verified 3 days ago
| Entity Name | Reconstructive Orthopaedic Associates Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861433278 PECOS PAC ID: 7416845318 Enrollment ID: O20040310000667 |
News Archive
In patients with non-small-cell lung cancer, rare epidermal growth factor receptor mutations are associated with a poorer response to EGFR–tyrosine kinase inhibitors compared with frequently occurring ones, according to a study published in Lung Cancer.
More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today at the 56th Annual Meeting of the American Society of Hematology.
A team led by University of Iowa researchers has identified a gene linked to rare, often fatal kidney-related birth defects.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yan Gu, MD 833 Chestnut St Ste 520, Philadelphia, PA 19107-4430 Ph: (800) 321-9999 | Yan Gu, MD 510 Township Line Rd Ste 110, Blue Bell, PA 19422-2721 Ph: (267) 339-3558 |
News Archive
In patients with non-small-cell lung cancer, rare epidermal growth factor receptor mutations are associated with a poorer response to EGFR–tyrosine kinase inhibitors compared with frequently occurring ones, according to a study published in Lung Cancer.
More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today at the 56th Annual Meeting of the American Society of Hematology.
A team led by University of Iowa researchers has identified a gene linked to rare, often fatal kidney-related birth defects.
› Verified 3 days ago
Donel Sequea, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 510 Township Line Rd Ste 110, Blue Bell, PA 19422 Phone: 800-321-9999 | |
Mathew J Abraham, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 725 Skippack Pike, Suite #130, Blue Bell, PA 19422 Phone: 267-462-4505 Fax: 267-462-4504 | |
Lauren F Vernese, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 510 Township Line Rd Ste 110, Blue Bell, PA 19422 Phone: 800-321-9999 Fax: 267-479-1321 | |
Dr. Kp Babu V Varada, M.D Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1630 Chadwyck Pl, Blue Bell, PA 19422 Phone: 215-370-9347 Fax: 215-591-3874 | |
Dr. Bernardine M Polish, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 10 Withers Ln, Blue Bell, PA 19422 Phone: 610-246-6054 |